<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941006-1-00150</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=11 g=1 f=1 --> The total value of the benefits of unit-dose packaging  <!-- PJG 0012 frnewline --> options is the sum of the value of reducing both mortality and  <!-- PJG 0012 frnewline --> morbidity risks. The selected option, requiring unit-dose  <!-- PJG 0012 frnewline --> packaging for all products containing 30 mg or more iron per  <!-- PJG 0012 frnewline --> dosage unit, would result in benefits of reducing mortality risks  <!-- PJG 0012 frnewline --> of between $280 million and $618 million and reduced morbidity  <!-- PJG 0012 frnewline --> valued at $61 million. Therefore, total discounted benefits of  <!-- PJG 0012 frnewline --> this option are between $315 million and $618 million. Table 7  <!-- PJG 0012 frnewline --> summarizes the costs and benefits of the packaging options.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 4,L2,i1,s30,6,12,12 -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Table  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=1 --> 10._ <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Costs and Benefits of Unit-Dose Packaging Options  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=96 g=1 f=4 --> [In millions of dollars] <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Trigger level  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Total costs  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Total benefits  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Net benefits <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=4 --> All products  <!-- PJG 007 0104 intable --> $299  <!-- PJG 007 0104 intable --> $341 to 679  <!-- PJG 007 0104 intable --> $42 to 380  <!-- PJG 0012 frnewline --> >30 mg  <!-- PJG 007 0104 intable --> 52  <!-- PJG 007 0104 intable --> 315 to 653  <!-- PJG 007 0104 intable --> 263 to 601  <!-- PJG 0012 frnewline --> >40 mg  <!-- PJG 007 0104 intable --> 35  <!-- PJG 007 0104 intable --> 315 to 653  <!-- PJG 007 0104 intable --> 280 to 618  <!-- PJG 0012 frnewline --> >60 mg  <!-- PJG 007 0104 intable --> 6  <!-- PJG 007 0104 intable --> 300 to 618  <!-- PJG 007 0104 intable --> 294 to 612 <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=81 g=1 f=4 --> 2. Warning Labels  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> a.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Costs. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Every petition submitted to FDA requested that  <!-- PJG 0012 frnewline --> the agency require that iron-containing product labels contain  <!-- PJG 0012 frnewline --> warning statements about the potentially fatal effects of  <!-- PJG 0012 frnewline --> pediatric poisonings from accidental ingestion of iron-containing  <!-- PJG 0012 frnewline --> products. The cost associated with warning statements are the  <!-- PJG 0012 frnewline --> cost of redesigning the label, disposing of old labels, and  <!-- PJG 0012 frnewline --> administrative costs. In January, 1994, FDA published final rules regarding nutrition labeling of dietary supplements in  <!-- PJG 0012 frnewline --> accordance with the Nutrition Labeling and Education Act of 1990  <!-- PJG 0012 frnewline --> (NLEA) and the Dietary Supplement Act of 1992. In its analysis  <!-- PJG 0012 frnewline --> of those rules (59 FR 352), FDA determined that the incremental  <!-- PJG 0012 frnewline --> cost of label changes for dietary supplement manufacturers is  <!-- PJG 0012 frnewline --> approximately $1,500 per label. FDA is proposing that the label  <!-- PJG 0012 frnewline --> warning statement be printed directly on the immediate container  <!-- PJG 0012 frnewline --> of the product, i.e., the container that holds the tablet or  <!-- PJG 0012 frnewline --> capsule, and on the principal display panel of the retail  <!-- PJG 0012 frnewline --> package, if such package is not the immediate container. If a  <!-- PJG 0012 frnewline --> product is sold in unit-dose packaging, the product would be  <!-- PJG 0012 frnewline --> required to bear the warning directly on each unit-dose package  <!-- PJG 0012 frnewline --> or on a strip of unit-dose packages in such a way that separating  <!-- PJG 0012 frnewline --> the unit-dose packages would not destroy the warning labeling.  <!-- PJG 0012 frnewline --> Manufacturers of all 300 iron-containing products will be  <!-- PJG 0012 frnewline --> required to change their labels on both the product container and  <!-- PJG 0012 frnewline --> the retail package to incorporate warning statements. However,  <!-- PJG 0012 frnewline --> because manufacturers of iron-containing products with 30 mg or  <!-- PJG 0012 frnewline --> more per dosage unit will also be required to change their  <!-- PJG 0012 frnewline --> packaging, they will not incur any incremental cost in adding a  <!-- PJG 0012 frnewline --> warning statement to the product container. Therefore, the  <!-- PJG 0012 frnewline --> labeling costs will be incurred by all 300 products for the  <!-- PJG 0012 frnewline --> retail package and for 150 products for the product container.  <!-- PJG 0012 frnewline --> The total cost would be a one-time cost of $675,000 (300 &times; 1.5 &times; $1,500).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            